Aura Biosciences (AURA) Retained Earnings (2020 - 2026)
Aura Biosciences (AURA) reported Retained Earnings of -$207000.0 for Q1 2026, up 99.95% on a YoY basis from -$103526.7 in Q1 2025, and up 99.96% quarter-over-quarter from -$480.4 million in Q4 2025.
Aura Biosciences (AURA) Retained Earnings (2020 - 2026) Analysis & Trends
Aura Biosciences has reported Retained Earnings for 7 years, with the latest figure at -$207000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 99.95% year-over-year to -$207000.0; the trailing twelve-month figure through Mar 2026 stood at -$207000.0 (up 99.95% YoY), and the FY2025 full-year result was -$480.4 million, down 182768.44% from the prior year.
- Retained Earnings for Q1 2026 stood at -$207000.0, up from -$480.4 million in the prior quarter.
- The five-year high for Retained Earnings was $263000.0 in Q4 2024, with the low at -$480.4 million in Q4 2025.
- Historically, Retained Earnings has averaged -$171.0 million across 5 years, with a median of -$194.3 million in 2022.
- Annual changes were most pronounced in 2023 — Retained Earnings tumbled 4567900.0% — and 2025, when it jumped 113.66%.
- Aura Biosciences' Retained Earnings stood at -$72000.0 in 2022, then tumbled by 398938.89% to -$287.3 million in 2023, then surged by 100.09% to $263000.0 in 2024, then plunged by 182768.44% to -$480.4 million in 2025, then jumped by 99.96% to -$207000.0 in 2026.
- The last three Retained Earnings figures came in at -$207000.0 (Q1 2026), -$480.4 million (Q4 2025), and -$454.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - | -207,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -207,000.00 |
| Dec 31, 2025 | -480.42 Mn |
| Sep 30, 2025 | -454.86 Mn |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | -401.71 Mn |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | -348.39 Mn |
| Jun 30, 2024 | -183,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | -287.31 Mn |
| Sep 30, 2023 | -265.20 Mn |
| Jun 30, 2023 | -246.70 Mn |
| Mar 31, 2023 | -228.40 Mn |
| Dec 31, 2022 | -72,000.00 |
| Sep 30, 2022 | -194.30 Mn |
| Jun 30, 2022 | -128,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | -152.14 Mn |
| Sep 30, 2021 | -140.50 Mn |
| Dec 31, 2020 | -116.89 Mn |